Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XC3V
|
||||
Former ID |
DNC004035
|
||||
Drug Name |
4-[1-(4-hydroxyphenyl)-2-phenylhex-1-enyl]phenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526457] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H24O2
|
||||
Canonical SMILES |
CCCCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=CC=C3
|
||||
InChI |
1S/C24H24O2/c1-2-3-9-23(18-7-5-4-6-8-18)24(19-10-14-21(25)15-11-19)20-12-16-22(26)17-13-20/h4-8,10-17,25-26H,2-3,9H2,1H3
|
||||
InChIKey |
LOSAKSLRALRQMY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [526457] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.